Nan Fung Group Holdings LTD Kodiak Sciences Inc. Transaction History

Nan Fung Group Holdings LTD

  • $103 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$3.01 - $7.45 $37,023 - $91,635
12,300 Added 62.68%
31,922 $167,000
Q1 2022

May 13, 2022
BUY
$7.09 - $89.45 $43,830 - $552,979
6,182 Added 46.0%
19,622 $151,000
Q4 2021

Feb 14, 2022
BUY
$80.85 - $128.49 $1.09 Million - $1.73 Million
13,440 New
13,440 $1.14 Million

Others Institutions Holding KOD

# of Institutions
97
Shares Held
39M
Call Options Held
6.5K
Put Options Held
5.8K
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $288M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Nan Fung Group Holdings LTD Portfolio

Follow Nan Fung Group Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nan Fung Group Holdings LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email